CEL-SCI To Sponsor Symposium On Multikine At European Congress On Head & Neck Oncology 2014

CEL-SCI Corporation (NYSE MKT: CVM), a late-stage oncology company, today announced that the Company is a Gold Sponsor of the European Congress on Head and Neck Oncology (ECHNO 2014), which will be held in Liverpool, England from April 24th through 26th, 2014. CEL-SCI will sponsor a symposium regarding its investigational immunotherapy candidate Multikine®* (Leukocyte Interleukin, Injection) and its ongoing Phase III head and neck cancer trial with Multikine. Company representatives will be available at conference booth #10.

Help employers find you! Check out all the jobs and post your resume.